日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PROX1 is an early driver of lineage plasticity in prostate cancer.

PROX1 是前列腺癌谱系可塑性的早期驱动因素

Duan Zhi, Shi Mingchen, Kumaraswamy Anbarasu, Lin Dong, Khokhani Dhruv, Wang Yong, Zhang Chao, Flores Diana, Rodansky Eva, Swaim Olivia A, Storck William K, Beck Hannah N, Patel Radhika A, Sayar Erolcan, Hanratty Brian P, Xue Hui, Dong Xin, Maylin Zoe R, Wan Rensheng, Quigley David A, Sjöström Martin, Hu Ya-Mei, Zhao Faming, Xia Zheng, Cheng Siyuan, Yu Xiuping, Feng Felix Y, Zhang Li, Aggarwal Rahul, Small Eric J, Ravikumar Visweswaran, Rao Arvind, Bedi Karan, Lee John K, Morrissey Colm, Coleman Ilsa, Nelson Peter S, Corey Eva, Udager Aaron M, Rebernick Ryan J, Cieslik Marcin P, Chinnaiyan Arul M, Yates Joel A, Haffner Michael C, Wang Yuzhuo, Alumkal Joshi J

Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancer.

转录组分析揭示了致命性前列腺癌中恩扎卢胺极度无反应的机制

Kumaraswamy Anbarasu, Hu Ya-Mei, Yates Joel A, Zhang Chao, Rodansky Eva, Khokhani Dhruv, Flores Diana, Duan Zhi, Zhang Yi, Tabatabaei Shaadi, Slottke Rachel, Ye Shangyuan, Lara Primo, Foye Adam, Ryan Charles J, Quigley David A, Huang Jiaoti, Aggarwal Rahul, Reiter Robert E, Wicha Max S, Beer Tomasz M, Rettig Matthew, Gleave Martin, Evans Christopher P, Witte Owen N, Stuart Joshua M, Thomas George V, Feng Felix Y, Small Eric J, Xia Zheng, Alumkal Joshi J

LSD1+8a is an RNA biomarker of neuroendocrine prostate cancer.

LSD1+8a 是神经内分泌前列腺癌的 RNA 生物标志物

Kumaraswamy Anbarasu, Mannan Rahul, Swaim Olivia A, Rodansky Eva, Wang Xiao-Ming, Udager Aaron, Mehra Rohit, Li Hui, Morrissey Colm, Corey Eva, Haffner Michael C, Nelson Peter S, Chinnaiyan Arul M, Yates Joel A, Alumkal Joshi J

Understanding Drug Sensitivity and Tackling Resistance in Cancer

了解癌症药物敏感性并克服耐药性

Tyner, Jeffrey W; Haderk, Franziska; Kumaraswamy, Anbarasu; Baughn, Linda B; Van Ness, Brian; Liu, Song; Marathe, Himangi; Alumkal, Joshi J; Bivona, Trever G; Chan, Keith Syson; Druker, Brian J; Hutson, Alan D; Nelson, Peter S; Sawyers, Charles L; Willey, Christopher D

BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program.

BET溴结构域抑制剂阻断了AR抑制、E2F1激活的治疗后出现的神经内分泌前列腺癌谱系可塑性程序

Kim Dae-Hwan, Sun Duanchen, Storck William K, Welker Leng Katherine, Jenkins Chelsea, Coleman Daniel J, Sampson David, Guan Xiangnan, Kumaraswamy Anbarasu, Rodansky Eva S, Urrutia Joshua A, Schwartzman Jacob A, Zhang Chao, Beltran Himisha, Labrecque Mark P, Morrissey Colm, Lucas Jared M, Coleman Ilsa M, Nelson Peter S, Corey Eva, Handelman Samuel K, Sexton Jonathan Z, Aggarwal Rahul, Abida Wassim, Feng Felix Y, Small Eric J, Spratt Daniel E, Bankhead Armand 3rd, Rao Arvind, Gesner Emily M, Attwell Sarah, Lakhotia Sanjay, Campeau Eric, Yates Joel A, Xia Zheng, Alumkal Joshi J

Recent Advances in Epigenetic Biomarkers and Epigenetic Targeting in Prostate Cancer

前列腺癌表观遗传生物标志物和表观遗传靶向治疗的最新进展

Kumaraswamy, Anbarasu; Welker Leng, Katherine R; Westbrook, Thomas C; Yates, Joel A; Zhao, Shuang G; Evans, Christopher P; Feng, Felix Y; Morgan, Todd M; Alumkal, Joshi J

Global Quantitative Proteomics reveal Deregulation of Cytoskeletal and Apoptotic Signalling Proteins in Oral Tongue Squamous Cell Carcinoma

全球定量蛋白质组学揭示口腔舌鳞状细胞癌中细胞骨架和凋亡信号蛋白的失调

Sivagnanam Ananthi, Ch Naga Padma Lakshmi, Paul Atmika, Kumaraswamy Anbarasu, Sundarasamy Mahalingam

Leucine Zipper Down-regulated in Cancer-1 (LDOC1) interacts with Guanine nucleotide binding protein-like 3-like (GNL3L) to modulate Nuclear Factor-kappa B (NF-κB) signaling during cell proliferation

癌症中下调的亮氨酸拉链-1 (LDOC1) 与鸟嘌呤核苷酸结合蛋白样 3 (GNL3L) 相互作用,在细胞增殖过程中调节核因子-κB (NF-κB) 信号传导

Indu Jose Thoompumkal, Krishnan Rehna, Kumaraswamy Anbarasu, Sundarasamy Mahalingam